Search
+
    Invest with Confidence. Lead with Insights.
    • Drench in the knowledge with exclusive insights, ePaper & smart market tools with ETPrime.

    Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%

    Synopsis

    In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started routing their business through them, they all lost their shine on the market and have still not got it back. But sometimes these stocks tend to fall less in volatile markets, does this make them a tactical buy? We take a look at 4 MNC pharma companies where analysts have a Buy and Hold recommendation.

    Post 2000 IT sector bull run, a set of Indian companies came into the limelight. Both from IT sector and non IT space. This was a fundamental shift in how India invested. There was a time when having MNC stock was a must have in one's portfolio. They reason, they were very liberal at giving bonuses, dividend payments were good and given the fact some of them actually owned the best of the brands, they had seen a secular growth, which meant they
    • FONT SIZE
    • SAVE
    • PRINT
    • COMMENT
    ET

    Uh-oh! This is an exclusive story available for selected readers only.

    Worry not. You’re just a step away.

    Why ?

    • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

    • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

    • Clean experience with
      Minimal Ads
    • Comment & Engage with ET Prime community
    • Exclusive invites to Virtual Events with Industry Leaders
    • A trusted team of Journalists & Analysts who can best filter signal from noise
    • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

    The Economic Times